Introducing the New Tirzepatide ELISA Kit (Mounjaro® - Zepbound®)
Tirzepatide has emerged as a groundbreaking dual agonist of the GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors, driving significant advancements in obesity, diabetes, and metabolic disease research. As the active pharmaceutical ingredient in Mounjaro® and Zepbound®, Tirzepatide continues to gain attention across translational and preclinical research programs.
To support the growing demand for reliable Tirzepatide analysis, BMA Biomedicals offers the Tirzepatide ELISA Kit (S-1552), a highly sensitive assay designed for accurate detection and quantification of Tirzepatide in research samples.
Key Features of the Tirzepatide ELISA Kit (S-1552)
✅ High Sensitivity Detection
Lower limit of detection (LOD): 1.4 ng/mL for precise measurement of low analyte concentrations.
✅ Excellent Quantitative Performance
Linear measurement range: 21-550 ng/mL with an average IC50 of 108 ng/mL.
✅ Broad Species Reactivity
Validated for use with samples from human, mouse, rat, porcine, bovine, chicken, monkey, and other vertebrate species.
✅ 96-Well Competitive ELISA Format
Optimized for research laboratories requiring reproducible and scalable workflows.
✅ Research-Grade Quality
Developed using highly specific antibodies to support pharmacokinetic, metabolic, and drug development studies.
Ideal Applications
- Tirzepatide pharmacokinetic studies
- GLP-1/GIP receptor agonist research
- Obesity and metabolic disease investigations
- Type 2 diabetes research
- Drug development and preclinical studies
- Biomarker and therapeutic monitoring research applications
With decades of expertise in peptide immunoassays and research reagents, BMA Biomedicals delivers trusted solutions for scientists worldwide. The Tirzepatide ELISA Kit (S-1552) combines sensitivity, specificity, and reproducibility to help accelerate your research outcomes.
Be among the first to integrate this essential tool into your research pipeline and contact us at info@bma.ch
We help you keep your research moving forward!
Your BMA team